 |
|
 |
Estonia |
|
|
The Pharmaceutical Market: Estonia
Publication Date December 2007
Publisher Espicom
Product Type Strategic Report
Pages 76
ISBN Number not applicable
Product Code ESP548
|
|
|
Summary
Espicom''s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
|
Content
- Executive Summary
- Pharmaceutical Market
- Current Size
- Projections
- Outlook
- Market Structure
- Retail Pharmacy Market
- Reimbursable Drugs - Retail Pharmacy Market
- Hospital Market
- Generics
- OTC Products
- Domestic Production
- Domestic Producers
- Multinationals
- International Trade
- Imports
- Research & Development
- Market Developments
- Health Insurance Expenditure to Rise by 3 4% in 2008
- Upturn in Spending on Reimbursable Products during First Half of 2007
- UCB Pharma to Restructure French Operations
- Chronic Conditions Set to Drive up Healthcare Spending
- Health Spending Grows at Lower Rate than GDP in 2006
- Government Implements New Cost Saving Programme to Address Health Deficit
- Cephalon Expands Pharmaceutical Production Unit at Nevers
- Generic Drugs Reduce Health Expenditure by 912 Million Euros in 2006
- Wockhardt Acquires Negma-Lerads
- Ipsen Expands Dreux Facility
- Pierre Fabre to Build New Active Ingredient Plant at Castres
- Genzyme to Build Biomanufacturing Plant in Lyon
- Merck Expands Mirabel Factory at Riom
- Sarkozy Health Reform Programme
- Revitalisation of the Self-Medication Market
- France Transposes EU Pharmaceutical Directive
- Pfizer Restructures French Operations
- AstraZeneca and GSK Sell French Production Units
- Initiatives to Boost Pharmaceutical Industry
- Servier Expands Croissy R&D Centre
- New Measures to Reduce Consumption of Antibiotics and Anti-ulcers
- Pharmaceutical Industry Continues to Bear Brunt of Cost-Saving Measures
- GSK to Expand Vaccine Production at Saint-Amand-Les Eaux
- Work Starts on Construction of Research Facilities at Toulouse Canceropole
- Key National Data Projections
- Methodology and Sources
- List of Tables
- Summary of the French Pharmaceutical Market in 2007
- Sales of Pharmaceuticals for Human Use, 2000-2006 (manufacturers' prices)
- Sales of Pharmaceuticals for Human Use, 2000-2006 (euros million)
- Projected Pharmaceutical Market, 2007-2012
- SWOT Analysis of the French Pharmaceutical Market
- Top 20 Therapeutic Classes in Retail Pharmacy Drug Market, 2006
- Top Selling Products' Share of the Retail Pharmacy Market, 2004-2006 (%)
- Top 50 Products in Retail Pharmacy Market by Value Ranking, 2006
- Growth in Pharmaceutical Consumption, Reimbursable Products, 2002-2006
- Reimbursable Pharmaceutical Growth by Principal Factor, 2000-2006 (%)
- Pharmacy Spending on Reimbursable Products by Reimbursement Status, 2005-2006
- Top Ten Contributors to Increased Spending on Reimbursable Products, 2006
- Top Ten Contributors to Reduced Spending on Reimbursable Products, 2006
- Top 50 Reimbursable Products Contributing to Spending Growth, 2004
- Top 20 Therapeutic Classes in Hospital Drug Market, 2006
- Top 50 Products in Hospital Market by Value Ranking, 2006
- Sales of Reimbursable Generics in Retail Pharmacy Market, 2002-2006
- Reimbursable Market by Patent Status, 2006
- Principal Molecules Coming off Patent, 2005-2007
- Generic Penetration Objectives by Volume for 2006
- Companies Serving the French Generics Market, 2006
- Pharmaceutical Production, 2000-2004 (billion euros)
- Summary of Pharmaceutical Exports, 2001-2005 (US$000s)
- Pharmaceutical Exports by Category, 2001-2005 (%)
- Growth of Pharmaceutical Exports, 2001-2005 (%)
- Leading Destinations of Pharmaceuticals, 2005 (US$000s)
- Leading Raw Material Destinations, 2005(US$000s)
- Leading Medicament Destinations, 2005(US$000s)
- Exports of Pharmaceuticals, 2001-2005 (US$000s)
- Export Trends, 2005 (US$000s)
- Exports by Leading Destinations, 2005 (US$000s)
- Balance of Trade, 2001-2005 (US$000s)
- Summary of Pharmaceutical Imports, 2001-2005 (US$000s)
- Distribution of Pharmaceutical Imports by Category, 2001-2005 (%)
- Growth of Pharmaceutical Imports, 2001-2005 (%)
- Leading Suppliers of Pharmaceuticals, 2005 (US$000s)
- Leading Suppliers of Pharmaceutical Raw Materials, 2005 (US$000s)
- Leading Suppliers of Medicaments, 2005 (US$000s)
- Imports of Pharmaceuticals, 2001-2005 (US$000s)
- Import Trends, 2005 (US$000s)
- Leading Suppliers, 2005 (US$000s)
- Pharmaceutical Industry R&D Expenditure, 1995-2002 (euros million)
- Growth in Patients Registered with Long Term Disorders (Rgime Gnrale)
- Trends in Pharmaceutical Expenditure, 2000-2006
- CNAM Cost Savings Measures Adopted by the Government
- Trends in Generic Drug Consumption, 2003-2006
- Antibiotic Consumption by Rgime Gnral Beneficiaries, 2004 - 2006
- Proposed Savings from Reduced Prescribing by Ambulatory Doctors, 2006-2007
- Key Data Projections, 2007-2012
- List of Figures
- Sales of Pharmaceuticals, 1996-2006 (manufacturers' prices)
- Pharmaceutical Market Growth Rates by Sector, 1996-2006
- Radar Graph of the French Healthcare System
- Retail Pharmacy Market by Product Status, 2006, Value % (Volume %)
- Retail Pharmacy Market: Turnover by Therapeutic Area, 2005 (%)
- Retail Pharmacy Market: Volume by Therapeutic Area, 2005 (%)
- Distribution of the Reimbursable Market by Age of Presentations, 2006 (%)
- Distribution of the OTC Pharmaceutical Market by Product Status, 2005 (%)
- Pharmaceutical Imports, Exports & Balance of Trade, 1997-2005 (US$000)
- Change in Imports & Exports, 1998-2005 (%)
- Annual Growth Rate in Spending on Reimbursable Drugs, 1995-2007 (%)
|
|
|
